haya therapeutics raised €58M in a Series A round in May 2025. The company is based in Lausanne, Switzerland. Investors in the round: +ND Capital, 4see Ventures, Alexandria Venture Investments and 9 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
